Garrison Pittsburgh Southside Opco LLC

WHEMCO Steel Castings Inc. is a global supplier of heavy industrial components serving the metals, power generation, mining, and shipbuilding industries through its five operating companies. Specializing in technical excellence across core competencies such as melting, casting, forging, heat treating, and machining, the company is committed to providing superior products that meet the most demanding customer requirements. Among WHEMCO's diverse product offerings are mill rolls, slag pots, large castings, ingots, billets, and open die forgings. The company prides itself on its quality, customer service, and vast capabilities, positioning itself as a leader in the heavy industrial components sector. Generated from the website

Noveome Biotherapeutics, Inc. is a pioneering biotechnology company based in Pittsburgh, PA, dedicated to advancing the field of regenerative medicine. Their groundbreaking ST266 biologic, a multi-targeted secretome containing numerous biologically active proteins and factors crucial to healing, holds significant clinical potential for a range of underserved conditions in ophthalmology, neurology, dermatology, and beyond. With a focus on innovative delivery options and scalable manufacturing, Noveome is committed to developing effective treatments that simulate natural healing processes. Their portfolio covers important ophthalmic indications, and their passionate and diverse team is dedicated to making a positive difference in patients' lives.Generated from the website

Peptilogics is a Pittsburgh-based company that aims to revolutionize the discovery process for novel peptide therapeutics, focusing on patients with serious and life-threatening diseases. By combining the untapped potential of peptide biology with the power of machine learning, Peptilogics utilizes precision engineering and design to create the next generation of medicines at a massive scale. With their AI platform, Peptilogics is able to transform peptide drug discovery by leveraging advancements in AI algorithms, supercomputing, and peptide R&D. Their approach efficiently accesses new functional chemical space to design peptides with optimized properties for success as drug candidates, targeting serious conditions with high unmet medical needs and accelerating discovery efforts previously deemed impossible.Generated from the website